UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 127

Sortiert nach

Phase I Clinical Trial of a Selective Inhibitor of CYP17, Abiraterone Acetate, Confirms That Castration-Resistant Prostate Cancer Commonly Remains Hormone Driven

Journal of clinical oncology, 2008-10, Vol.26 (28), p.4563-4571

2008

Volltextzugriff (PDF)

Phase I/II Trial and Pharmacokinetic Study of Cixutumumab in Pediatric Patients With Refractory Solid Tumors and Ewing Sarcoma: A Report From the Children's Oncology Group

Journal of clinical oncology, 2012-01, Vol.30 (3), p.256-262

2012

Volltextzugriff (PDF)

Effects of Aerobic and Resistance Exercise in Breast Cancer Patients Receiving Adjuvant Chemotherapy: A Multicenter Randomized Controlled Trial

Journal of clinical oncology, 2007-10, Vol.25 (28), p.4396-4404

2007

Volltextzugriff (PDF)

Randomized Controlled Trial of Resistance or Aerobic Exercise in Men Receiving Radiation Therapy for Prostate Cancer

Journal of clinical oncology, 2009-01, Vol.27 (3), p.344-351

2009

Volltextzugriff (PDF)

Phase I Pharmacokinetic and Pharmacodynamic Study of Pazopanib in Children With Soft Tissue Sarcoma and Other Refractory Solid Tumors: A Children's Oncology Group Phase I Consortium Report

Journal of clinical oncology, 2013-08, Vol.31 (24), p.3034-3043

2013

Volltextzugriff (PDF)

Phase I Trial and Pharmacokinetic Study of Bevacizumab in Pediatric Patients With Refractory Solid Tumors: A Children's Oncology Group Study

Journal of clinical oncology, 2008-01, Vol.26 (3), p.399-405

2008

Volltextzugriff (PDF)

Randomized Phase III Trial of Ganitumab With Interval-Compressed Chemotherapy for Patients With Newly Diagnosed Metastatic Ewing Sarcoma: A Report From the Children's Oncology Group

Journal of clinical oncology, 2023-04, Vol.41 (11), p.2098-2107

2023

Volltextzugriff (PDF)

Resistance Exercise in Men Receiving Androgen Deprivation Therapy for Prostate Cancer

Journal of clinical oncology, 2003-05, Vol.21 (9), p.1653-1659

2003

Volltextzugriff (PDF)

Relapsed or Refractory Double-Expressor and Double-Hit Lymphomas Have Inferior Progression-Free Survival After Autologous Stem-Cell Transplantation

Journal of clinical oncology, 2017-01, Vol.35 (1), p.24-31

2017

Volltextzugriff (PDF)

Phase II Trial of Vorinostat in Recurrent Glioblastoma Multiforme: A North Central Cancer Treatment Group Study

Journal of clinical oncology, 2009-04, Vol.27 (12), p.2052-2058

2009

Volltextzugriff (PDF)

Palliation of pain associated with metastatic bone cancer using samarium-153 lexidronam: a double-blind placebo-controlled clinical trial

Journal of clinical oncology, 1998-04, Vol.16 (4), p.1574-1581

1998

Volltextzugriff (PDF)

Phase III Trial of Doxorubicin Plus Cisplatin With or Without Paclitaxel Plus Filgrastim in Advanced Endometrial Carcinoma: A Gynecologic Oncology Group Study

Journal of clinical oncology, 2004-06, Vol.22 (11), p.2159-2166

2004

Volltextzugriff (PDF)

Chemoimmunotherapy Reinduction With Epratuzumab in Children With Acute Lymphoblastic Leukemia in Marrow Relapse: A Children's Oncology Group Pilot Study

Journal of clinical oncology, 2008-08, Vol.26 (22), p.3756-3762

2008

Volltextzugriff (PDF)

Phase II Study of Gemcitabine, Carboplatin, and Iniparib As Neoadjuvant Therapy for Triple-Negative and BRCA1/2 Mutation-Associated Breast Cancer With Assessment of a Tumor-Based Measure of Genomic Instability: PrECOG 0105

Journal of clinical oncology, 2015-06, Vol.33 (17), p.1895-1901

2015

Volltextzugriff (PDF)

Phase II Study of Selumetinib in Children and Young Adults With Tumors Harboring Activating Mitogen-Activated Protein Kinase Pathway Genetic Alterations: Arm E of the NCI-COG Pediatric MATCH Trial

Journal of clinical oncology, 2022-07, Vol.40 (20), p.2235-2245

2022

Volltextzugriff (PDF)

Cancer Genomics: Technology, Discovery, and Translation

Journal of clinical oncology, 2012-02, Vol.30 (6), p.647-660

2012

Volltextzugriff (PDF)

Phase I Trial of Oral Fenretinide in Children With High-Risk Solid Tumors: A Report From the Children's Oncology Group (CCG 09709)

Journal of clinical oncology, 2006-07, Vol.24 (21), p.3423-3430

2006

Volltextzugriff (PDF)

Phase I Trial of 17-Allylamino-17-Demethoxygeldanamycin in Patients With Advanced Cancer

Journal of clinical oncology, 2005-02, Vol.23 (6), p.1078-1087

2005

Volltextzugriff (PDF)

Phase I and Pharmacodynamic Study of the Oral MEK Inhibitor CI-1040 in Patients With Advanced Malignancies

Journal of clinical oncology, 2005-08, Vol.23 (23), p.5281-5293

2005

Volltextzugriff (PDF)

Clinical Characteristics of Individuals With Germline Mutations in BRCA1 and BRCA2: Analysis of 10,000 Individuals

Journal of clinical oncology, 2002-03, Vol.20 (6), p.1480-1490

Frank, T. S.

2002

Volltextzugriff (PDF)

Overall survival in patients with metastatic or locally advanced pancreatic cancer following chemoradiation with novel combination of aldoxorubicin, N-803 IL-15 superagonist, and PDL1- NK cell therapy

Journal of clinical oncology, 2023-02, Vol.41 (4_suppl), p.720-720

2023

Volltextzugriff (PDF)

Structured Exercise Improves Physical Functioning in Women With Stages I and II Breast Cancer: Results of a Randomized Controlled Trial

Journal of clinical oncology, 2001-02, Vol.19 (3), p.657-665

2001

Volltextzugriff (PDF)

Phase I Trial and Pharmacokinetics of Gemcitabine in Children With Advanced Solid Tumors

Journal of clinical oncology, 2004-06, Vol.22 (12), p.2445-2451

2004

Volltextzugriff (PDF)

Phase 2 study of larotrectinib in children with newly diagnosed infantile fibrosarcoma (IFS): Children’s Oncology Group (COG) ADVL1823 cohort A

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.10008-10008

2023

Volltextzugriff (PDF)

1 – 25 von 127

Suche als RSS-Feed

Aktive Filter

PublikationsformDatensätze

Zeitschrift / SerieJournal Of Clinical Oncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(127)
Mit Volltextzugriff
(127)

Publikationsform

Artikel
(127)

Sprache

Englisch
(127)
Japanisch
(9)

Erscheinungsjahr

n.n

Thema

Oncology
(31)
Life Sciences & Biomedicine
(30)
Science & Technology
(30)
Humans
(27)
Biological And Medical Sciences
(24)
Medical Sciences
(24)
Female
(21)
Male
(19)
Tumors
(18)
Adult
(17)
Middle Aged
(16)
Aged
(14)
Treatment Outcome
(10)
Adolescent
(7)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(7)
Child
(7)
Child, Preschool
(7)
Original Reports
(7)
Neoplasms - Drug Therapy
(6)
Aged, 80 And Over
(5)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

1 weiteren anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Phase I Clinical Trial of a Selective Inhibitor of CYP17, Abiraterone Acetate, Confirms That Castration-Resistant Prostate Cancer Commonly Remains Hormone Driven

Phase I/II Trial and Pharmacokinetic Study of Cixutumumab in Pediatric Patients With Refractory Solid Tumors and Ewing Sarcoma: A Report From the Children's Oncology Group

Effects of Aerobic and Resistance Exercise in Breast Cancer Patients Receiving Adjuvant Chemotherapy: A Multicenter Randomized Controlled Trial

Randomized Controlled Trial of Resistance or Aerobic Exercise in Men Receiving Radiation Therapy for Prostate Cancer

Phase I Pharmacokinetic and Pharmacodynamic Study of Pazopanib in Children With Soft Tissue Sarcoma and Other Refractory Solid Tumors: A Children's Oncology Group Phase I Consortium Report

Phase I Trial and Pharmacokinetic Study of Bevacizumab in Pediatric Patients With Refractory Solid Tumors: A Children's Oncology Group Study

Randomized Phase III Trial of Ganitumab With Interval-Compressed Chemotherapy for Patients With Newly Diagnosed Metastatic Ewing Sarcoma: A Report From the Children's Oncology Group

Resistance Exercise in Men Receiving Androgen Deprivation Therapy for Prostate Cancer

Relapsed or Refractory Double-Expressor and Double-Hit Lymphomas Have Inferior Progression-Free Survival After Autologous Stem-Cell Transplantation

Phase II Trial of Vorinostat in Recurrent Glioblastoma Multiforme: A North Central Cancer Treatment Group Study

Randomized Phase II Trial of Endocrine Therapy With or Without Ribociclib After Progression on Cyclin-Dependent Kinase 4/6 Inhibition in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer: MAINTAIN Trial

Palliation of pain associated with metastatic bone cancer using samarium-153 lexidronam: a double-blind placebo-controlled clinical trial

Phase III Trial of Doxorubicin Plus Cisplatin With or Without Paclitaxel Plus Filgrastim in Advanced Endometrial Carcinoma: A Gynecologic Oncology Group Study

Chemoimmunotherapy Reinduction With Epratuzumab in Children With Acute Lymphoblastic Leukemia in Marrow Relapse: A Children's Oncology Group Pilot Study

Phase II Study of Gemcitabine, Carboplatin, and Iniparib As Neoadjuvant Therapy for Triple-Negative and BRCA1/2 Mutation-Associated Breast Cancer With Assessment of a Tumor-Based Measure of Genomic Instability: PrECOG 0105

Phase II Study of Selumetinib in Children and Young Adults With Tumors Harboring Activating Mitogen-Activated Protein Kinase Pathway Genetic Alterations: Arm E of the NCI-COG Pediatric MATCH Trial

Cancer Genomics: Technology, Discovery, and Translation

Phase I Trial of Oral Fenretinide in Children With High-Risk Solid Tumors: A Report From the Children's Oncology Group (CCG 09709)

Phase I Trial of 17-Allylamino-17-Demethoxygeldanamycin in Patients With Advanced Cancer

Phase I and Pharmacodynamic Study of the Oral MEK Inhibitor CI-1040 in Patients With Advanced Malignancies

Clinical Characteristics of Individuals With Germline Mutations in BRCA1 and BRCA2: Analysis of 10,000 Individuals

Overall survival in patients with metastatic or locally advanced pancreatic cancer following chemoradiation with novel combination of aldoxorubicin, N-803 IL-15 superagonist, and PDL1- NK cell therapy

Structured Exercise Improves Physical Functioning in Women With Stages I and II Breast Cancer: Results of a Randomized Controlled Trial

Phase I Trial and Pharmacokinetics of Gemcitabine in Children With Advanced Solid Tumors

Phase 2 study of larotrectinib in children with newly diagnosed infantile fibrosarcoma (IFS): Children’s Oncology Group (COG) ADVL1823 cohort A

Aktive Filter

Suchergebnisse filtern